Year archive

Moberg Pharma — 2015 filings

All 55 regulatory filings released by Moberg Pharma (MOB) in 2015, sourced directly from the official regulator.

55 Filings

2015 Period

2015 filings (55)

Filing	Released	Lang
Förändring av antalet aktier och röster i Moberg Pharma Share Issue/Capital Change	2015-12-30	Swedish
Change in number of shares and votes in Moberg Pharma Declaration of Voting Results & Voting Rights Announcements	2015-12-30	English
Moberg Pharma expects to announce phase II data for BUPI in January Regulatory Filings	2015-12-22	English
Moberg Pharma räknar med att tillkännage fas II-data för BUPI i januari Regulatory Filings	2015-12-22	Swedish
Major Shareholding Notification 2015 Major Shareholding Notification	2015-12-07	English
Major Shareholding Notification 2015 Major Shareholding Notification	2015-11-25	English
Moberg Pharmas valberedning utsedd Regulatory Filings	2015-11-17	Swedish
Moberg Pharma’s Nomination Committee appointed AGM Information	2015-11-17	English
Earnings Release 2015 Earnings Release 9M 2015	2015-11-10	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report Q3 2015	2015-11-10	English
Moberg Pharma regains rights to Emtrix® in certain EU markets Legal Proceedings Report	2015-11-10	English
Moberg Pharma återfår rätten till Emtrix® på vissa EU-marknader Regulatory Filings	2015-11-10	Swedish
Moberg Pharma och Colep ingår avtal för vidareutveckling av MOB-015 Capital/Financing Update	2015-11-03	Swedish
Moberg Pharma and Colep enters Development agreement for late-stage development of MOB-015 Capital/Financing Update	2015-11-03	English
Major Shareholding Notification 2015 Major Shareholding Notification	2015-09-30	English
Major Shareholding Notification 2015 Major Shareholding Notification	2015-08-13	English
Interim / Quarterly Report 2015 Interim / Quarterly Report H1 2015	2015-08-11	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report Q2 2015	2015-08-11	English
Change in number of shares and votes in Moberg Pharma Declaration of Voting Results & Voting Rights Announcements	2015-07-31	English
Förändring av antalet aktier och röster i Moberg Pharma Share Issue/Capital Change	2015-07-31	Swedish
Moberg Pharma tilldelas 0.9 miljoner Euro i forskningsanslag från Eurostars Capital/Financing Update	2015-06-24	Swedish
Moberg Pharma to receive Eurostars grant of EUR 0.9 million Regulatory Filings	2015-06-24	English
Moberg Pharma får Europa-patent för Kerasal Nail Regulatory Filings	2015-05-28	Swedish
Moberg Pharma announces issue of European Patent for Kerasal Nail Regulatory Filings	2015-05-28	English
Moberg Pharmas partner lanserar Kerasal Nail i Kina Regulatory Filings	2015-05-19	Swedish
Moberg Pharma’s partner launches Kerasal Nail in China Regulatory Filings	2015-05-19	English
BULLETIN FROM MOBERG PHARMA’S ANNUAL GENERAL MEETING 2014 AGM Information	2015-05-11	English
KOMMUNIKÉ FRÅN MOBERG PHARMAS ÅRSSTÄMMA 2015 AGM Information	2015-05-11	Swedish
Earnings Release 2015 Earnings Release Q1 2015	2015-05-11	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-05-11	English
Moberg Pharma acquires U.S OTC brand Balmex® M&A Activity	2015-04-27	English
Moberg Pharma förvärvar receptfria produkter i USA M&A Activity	2015-04-27	Swedish
Major Shareholding Notification 2015 Major Shareholding Notification	2015-04-10	English
Kallelse till årsstämma i Moberg Pharma AB (publ) AGM Information	2015-04-09	Swedish
Notice of Annual General Meeting in Moberg Pharma AB (publ) AGM Information	2015-04-09	English
Annual Report 2014 Annual Report FY 2014	2015-04-09	Swedish
Annual Report 2014 Annual Report FY 2014	2015-04-09	English
Moberg Pharma announces grant of EU Patent for MOB-015 related to topical treatment of onychomycosis (nail fungus) Regulatory Filings	2015-03-26	English
Moberg Pharma får godkänt EU patent för MOB-015 mot nagelsvamp Regulatory Filings	2015-03-26	Swedish
Moberg Pharma announces issue of U.S. Patent for Kerasal Nail Regulatory Filings	2015-03-25	English
Moberg Pharma får USA patent för Kerasal Nail Regulatory Filings	2015-03-25	Swedish
MOB-015 data to be presented at the 73rd Annual Meeting of the American Academy of Dermatology AGM Information	2015-03-13	English
MOB-015 data kommer att presenteras på American Academy of Dermatology Regulatory Filings	2015-03-13	Swedish
Earnings Release 2014 Earnings Release Q4 2014	2015-02-27	Swedish
Audit Report / Information 2014 Audit Report / Information FY 2014	2015-02-27	English
Invitation - Presentation of Moberg Pharma's fourth quarter and full year results 2014 Report Publication Announcement	2015-02-18	English
Inbjudan - Presentation av Moberg Pharmas resultat för det fjärde kvartalet samt helåret 2014 Report Publication Announcement	2015-02-18	Swedish
Moberg Pharma launches innovative new Kerasal product in the U.S. Regulatory Filings	2015-02-13	English
Moberg Pharma lanserar ny Kerasal produkt i USA Regulatory Filings	2015-02-13	Swedish
Moberg Pharma får godkänt patent i USA för MOB-015 Regulatory Filings	2015-02-11	Swedish
Moberg Pharma announces issue of U.S. Patent related to MOB-015 for the treatment of Onychomycosis Regulatory Filings	2015-02-11	English
Moberg Pharma Extends Distribution Agreement with Menarini Group for Emtrix to Russia Regulatory Filings	2015-02-09	English
Moberg Pharma och Menarini Group expanderar samarbete för Emtrix till Ryssland Regulatory Filings	2015-02-09	Swedish
Moberg Pharma’s fungal nail product approved in China Regulatory Filings	2015-01-27	English
Moberg Pharmas nagelsvampsprodukt godkänd i Kina Regulatory Filings	2015-01-27	Swedish

Filings by year

2026 11 filings
2025 36 filings
2024 62 filings
2023 56 filings
2022 40 filings
2021 39 filings
2020 62 filings
2019 83 filings
2018 53 filings
2017 44 filings
2016 70 filings
2015 55 filings
2014 48 filings
2013 51 filings
2012 56 filings
2011 16 filings